156 / 490
154
SCIENTIFIC PROGRAMME
| PROGRAMME AND EXHIBITION GUIDE
INTERDISCIPLINARY RADIOBIOLOGY
CLINICAL BRACHYTHERAPY PHYSICS
RTT
YOUNG
TUESDAY 3 MAY 2016
09:47 > Automated QA using log files
Speaker: V. Hernandez (Spain)
SP-0598
10:07 > Automation in patient specific QA using in vivo portal dosimetry
Speaker: P. Francois (France)
SP-0599
Symposium
MANAGEMENT AND OPTIMISATION OF THE DAILYWORKFLOW
09:15 - 10:30 | ROOM 3
Implementation of workflow management systems in a department is a real asset for continuous quality
improvement and increased efficiency. In order to properly implement workflow management systems,
it is important to properly define the current workflow of the department while allowing enough flex-
ibility to integrate modifications emanating from improvement action or process changes.
These systems are also tightly linked to patient safety. Improvement and continuous development of
this important aspect depends also on the possibility to measure it. Patient safety culture is a complex
phenomenon and quantitative and qualitative measures should be combined to increase understand-
ing in the actual effects.
Lean can serve as an overall philosophy to create quality/safety improvement. In addition to the cultural
aspects, also structural elements and clinical process improvements should be addressed.
Lastly, we will see a model to plan the number of therapy units according to demographical and epide-
miological aspects.
Chair: D. Pasini (Italy)
Co-chair: P. Cornacchione (Italy)
09:15 > Optimising workflow using a workflow management system
Speaker: A. Vaandering (Belgium)
SP-0600
09:40 > Does lean management improve patient safety culture?
Speaker: P. Simons (The Netherlands)
SP-0601
10:05 > The impact of demographics trend, cancer incidence and cancer
prevalence for planning numbers of treatment units in Austria
Speaker: A. Osztavics (Austria)
SP-0602
Symposium
COMBINING RADIOTHERAPYWITHMOLECULAR TARGETED AGENTS:
LEARNING FROM SUCCESSES AND FAILURES
11:00 - 12:00 | ROOM 2
In this session, the rationale for combining radiation and molecular targeted agents in cancer therapy
will be described with a focus on targeting of EGFR, the immune system and tumor angiogenesis and
hypoxia. For the combination of radiation with immunotherapy, examples of proimmunogenic and
immunosuppressive effects of radiation and differences in the effect based on dose and fractionation